RGEN
REPLIGEN CORP
REPLIGEN CORP (RGEN) has 19 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 17, 2026.
Insiders have net sold $722K over the trailing 6 months.
- Industry:Medical - Instruments & Supplies
- CEO:Olivier Loeillot
- Employees:1,778
- HQ:Waltham, MA, US
- IPO:1986-04-29
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$722K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$8.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| CFO | Sale | 530 | $80K | Jul 17 | SEC ↗ | |
Garland Jason KFirst filing | CFO | Sale | 733 | $106K | Jun 26 | SEC ↗ |
Loeillot OlivierFirst filing | Chief Executive Officer | Sale | 3,832 | $536K | Apr 22 | SEC ↗ |
Related companies
REPLIGEN CORP is in the Healthcare sector.